Literature DB >> 8097573

Lack of interaction between alpha 2-adrenoceptors and dopamine D2-receptors in mediating their inhibitory effects on [3H]dopamine release from rat nucleus accumbens slices.

V A Russell1, M C Lamm, J J Taljaard.   

Abstract

The alpha 2-adrenoceptor agonist, UK14304, dose-dependently inhibited the electrically stimulated release of dopamine (DA) from rat nucleus accumbens slices. This effect was antagonized by idazoxan, confirming that it was an alpha 2-adrenoceptor mediated effect. There was no evidence of endogenous activation of noradrenergic receptors suggesting that the alpha 2-adrenoceptor agonist was not acting presynaptically to inhibit noradrenaline release. An in vitro superfusion technique was used to investigate whether there was any interaction between alpha 2-adrenoceptors and DA D2-receptors in mediating their inhibitory effects on [3H]DA release from rat nucleus accumbens slices. alpha 2-Adrenoceptors and DA D2-receptors interact with similar second messenger systems and it was considered that they may compete for a common pool of G-proteins. The inhibitory effects of the alpha 2-adrenoceptor agonist, UK14304, and the DA receptor agonists, quinpirole, apomorphine and pergolide were not independent. However, there was no evidence of any interaction between UK14304 and the DA D2-receptor antagonists, sulpiride or haloperidol, suggesting that the two receptors do not compete for a common pool of G-proteins in mediating their inhibitory effects on DA release.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097573     DOI: 10.1007/bf00969084

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway.

Authors:  B Drukarch; E Schepens; J C Stoof
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

2.  Multiple second messenger pathways of alpha-adrenergic receptor subtypes expressed in eukaryotic cells.

Authors:  S Cotecchia; B K Kobilka; K W Daniel; R D Nolan; E Y Lapetina; M G Caron; R J Lefkowitz; J W Regan
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

3.  Characterization of alpha 2-adrenoceptors which increase potassium conductance in rat locus coeruleus neurones.

Authors:  J T Williams; G Henderson; R A North
Journal:  Neuroscience       Date:  1985-01       Impact factor: 3.590

4.  Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.

Authors:  D M Cooper; C M Bier-Laning; M K Halford; M K Ahlijanian; N R Zahniser
Journal:  Mol Pharmacol       Date:  1986-02       Impact factor: 4.436

5.  Presynaptic kappa-opioid receptors on noradrenergic nerve terminals couple to G proteins and interact with the alpha 2-adrenoceptors.

Authors:  C Allgaier; B Daschmann; J Sieverling; G Hertting
Journal:  J Neurochem       Date:  1989-11       Impact factor: 5.372

6.  High plasma norepinephrine levels in patients with major affective disorder.

Authors:  C R Lake; D Pickar; M G Ziegler; S Lipper; S Slater; D L Murphy
Journal:  Am J Psychiatry       Date:  1982-10       Impact factor: 18.112

7.  Characterization of the synaptosomal high-affinity uptake of noradrenaline in the nucleus accumbens of rats.

Authors:  L Hetey; B Zimmermann
Journal:  Biomed Biochim Acta       Date:  1986

8.  Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons.

Authors:  J E Freedman; G K Aghajanian
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

9.  Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in primary unipolar major depressive disorder.

Authors:  A S de Villiers; V A Russell; M E Carstens; C Aalbers; C A Gagiano; D O Chalton; J J Taljaard
Journal:  Psychiatry Res       Date:  1987-10       Impact factor: 3.222

10.  Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices.

Authors:  M Pizzi; M Da Prada; A Valerio; M Memo; P F Spano; W E Haefely
Journal:  Brain Res       Date:  1988-07-26       Impact factor: 3.252

View more
  5 in total

Review 1.  The anatomy of co-morbid neuropsychiatric disorders based on cortico-limbic synaptic interactions.

Authors:  S Totterdell
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

2.  Presynaptic alpha 2A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices.

Authors:  A U Trendelenburg; K Starke; N Limberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

3.  Accumbal noradrenaline that contributes to the alpha-adrenoceptor-mediated release of dopamine from reserpine-sensitive storage vesicles in the nucleus accumbens is derived from alpha-methyl-para-tyrosine-sensitive pools.

Authors:  M M M Verheij; A R Cools
Journal:  J Neural Transm (Vienna)       Date:  2009-02-17       Impact factor: 3.575

4.  Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder.

Authors:  A S de Villiers; V A Russell; T Sagvolden; A Searson; A Jaffer; J J Taljaard
Journal:  Neurochem Res       Date:  1995-04       Impact factor: 3.996

5.  Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors.

Authors:  Francisca Meyer; Judith Latour; Alexander R Cools; Michel M M Verheij
Journal:  Front Cell Neurosci       Date:  2014-08-21       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.